Gestonorone Caproate

Subscribe to Selected New Research on Gestonorone Caproate

23 relevant articles (0 outcomes, 3 trials/studies) found for this Bio-Agent

Description: A long-acting potent progestogen structurally related to PROGESTERONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1185)

Also Known As:

Depostat; Gestronol; Gestronol Hexanoate; Primostat; Schering Brand of Gestonorone Caproate; Caproate, Gestonorone; Hexanoate, Gestronol; 19-Norpregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)-

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Gestonorone Caproate: 23

Pregnanes: 3

Pregnenes

Pregnenediones

Gestonorone Caproate: 23

Related Diseases

1.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/01/1971 - "Evaluation of Depostat in prostatic adenoma on the ground of clinical and sphincterotonometric studies." 07/16/1984 - "Treatment of benign prostatic hypertrophy with gestonorone caproate]" 09/01/1980 - "Results of treating prostatic adenoma with Depostat]" 09/14/1973 - "Depostat for benign prostatic hyperplasia?" 02/01/1972 - "Clinical trial of gestronol hexanoate (SH582) in benign prostatic hypertrophy." Get all the results and reference details, order at left...
2.	Hyperplasia 01/01/1977 - "A study was carried out in 30 male patients with benign prostate hyperplasia to assess the effectiveness of treatment with a progestational agent, gestonorone caproate (200 mg), given intramucularly every 7 days over a period of 2 to 3 months" Get all the results and reference details, order at left...
3.	Endometrial Neoplasms (Endometrial Cancer) 01/01/1972 - "20 patients with endometrial carcinoma received injections of 17-hydroxynorprogesterone capronate (Depostat, average dose 1000 mg) within 14 days after a 1st abrasion" Get all the results and reference details, order at left...
4.	Postmenopausal Osteoporosis 02/01/1978 - "1. The value of progestogen therapy in the prevention of postmenopausal bone loss was assessed in 30 women, by a preliminary randomized controlled trial of gestronol or mestranol, in comparison with a placebo" Get all the results and reference details, order at left...
5.	Cystadenocarcinoma 07/01/1979 - "The treatment of advanced cystadenocarcinoma of the ovary with gestronol and continuous oral cyclophosphamide." 07/01/1979 - "Fifty-four patients with advanced cystadenocarcinoma of the ovary were treated with gestronol (Depostat), 200 mg/week, by intramuscular injection and continuous oral cyclophosphamide, the dose of the latter being varied to maintain the patient's white cell count at about 1.5 x 10(9)/l" Get all the results and reference details, order at left...
7 Diseases and 23 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cyproterone Acetate
2.	Testosterone (Sustanon)
3.	Progesterone
4.	Progestins (Progestagens)
5.	Gestonorone Caproate
6.	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)
7.	Mestranol
8.	Estradiol (Estrace)
9.	Diethylstilbestrol (Stilbestrol)
10.	Cyclophosphamide (Cytoxan)
11 Drugs and Important Bio-Agents and 10 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>